Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2001
10/10/2001EP1140882A1 Piperazine ethylamide derivatives with 5-ht1a receptor activity
10/10/2001EP1140881A1 Antithrombotic amides
10/10/2001EP1140880A1 Homopiperazine derivatives as selective emopamil inhibitors
10/10/2001EP1140879A1 1-phenyl-4-(1- 2-aryl]cyclopropyl) methylpiperazines: dopamine receptor ligands
10/10/2001EP1140878A1 Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them ( inhibitio of factor xa activity )
10/10/2001EP1140877A1 Hypolipidemic and antioxidant morpholine derivatives
10/10/2001EP1140876A1 Morpholinone and morpholine derivatives and uses thereof
10/10/2001EP1140875A1 Sulphonyloxazolamines as therapeutic active ingredients
10/10/2001EP1140873A1 Il-5 inhibiting 6-azauracil derivatives
10/10/2001EP1140871A1 Thrombin or factor xa inhibitors
10/10/2001EP1140867A1 New beta-amide and beta-sulfonamide carboxylic acid derivatives, their preparation and their use as endothelin receptor antagonists
10/10/2001EP1140863A1 1,4-diazacycloheptane derivatives useful in the treatment of neurological disorders
10/10/2001EP1140862A1 THROMBIN OR FACTOR Xa INHIBITORS
10/10/2001EP1140861A1 Novel polyhydroxypyrazine derivatives, preparation and pharmaceutical compositions containing same
10/10/2001EP1140860A1 Pyrimidine compounds
10/10/2001EP1140859A2 (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors
10/10/2001EP1140858A2 Arylpropenylimidazoles as farnesyl-protein transferase inhibitors
10/10/2001EP1140855A1 Tetrahydroindazole derivatives as ligands for gaba-a alpha 5 receptors
10/10/2001EP1140852A1 1,2,3,4-tetrahydronaphthalenes and their pharamaceutical use
10/10/2001EP1140851A1 4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
10/10/2001EP1140850A1 Quinolinecarboxamides as antiviral agents
10/10/2001EP1140849A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
10/10/2001EP1140848A2 Phenethyl-5-bromopyridylthiourea (pbt) and dihydroalkoxybenzyloxopyrimidine (dabo) derivatives exhibiting spermicidal activity
10/10/2001EP1140844A1 Process for the formation of intermediates useful for the preparation of pharmaceuticals
10/10/2001EP1140840A1 -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
10/10/2001EP1140839A1 Heterocyclic amides as inhibitors of factor xa
10/10/2001EP1140838A1 1, 4-piperazine derivatives having 5ht1a receptor activity
10/10/2001EP1140836A1 Amide compounds
10/10/2001EP1140835A1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
10/10/2001EP1140831A1 Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine urea derivatives having 5ht1a receptor activity
10/10/2001EP1140830A1 Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine amide derivatives having 5ht1a receptor activity
10/10/2001EP1140829A1 Contrast media for angiography
10/10/2001EP1140828A1 3-azabicyclo[3.1.0]hexane derivatives as opiate receptors ligands
10/10/2001EP1140825A1 Melatonin derivatives and medicine containing same
10/10/2001EP1140823A1 Glucagon antagonists/inverse agonists
10/10/2001EP1140822A1 Stable activated novel carbamic acid derivatives, preparation method and use for preparing urea
10/10/2001EP1140821A1 Lactams
10/10/2001EP1140820A1 New amidino derivatives and their use as thrombin inhibitors
10/10/2001EP1140818A1 Amidomalonamides and their use as inhibitors of matrix metalloproteinase
10/10/2001EP1140815A1 Novel thio-aminotetralin compounds useful in pain management
10/10/2001EP1140814A2 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/10/2001EP1140810A1 Benzenic sulphonamide derivatives and their uses
10/10/2001EP1140809A1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
10/10/2001EP1140805A1 Amido polybiguanides and the use thereof as antimicrobial agents
10/10/2001EP1140803A1 ((aminoiminomethyl) amino) alkanecarboxamides and their applications in therapy
10/10/2001EP1140802A1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines
10/10/2001EP1140792A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives which inhibit leukocyte adhesion mediated by vla-4
10/10/2001EP1140790A1 Novel oxo-aminotetralin compounds useful in pain management
10/10/2001EP1140786A1 Reductive alkylation of secondary amines with hydrosilane
10/10/2001EP1140784A2 Ion channel modulating agents
10/10/2001EP1140783A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp
10/10/2001EP1140768A1 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
10/10/2001EP1140745A1 Colchinol derivatives as vascular damaging agents
10/10/2001EP1140733A1 Process and products of purification of anhydrosugar alcohols
10/10/2001EP1140291A1 Combination chemotherapy comprising a mitotic inhibitor and a mek inhibitor
10/10/2001EP1140290A2 Synergistic tumorcidal response induced by histamine
10/10/2001EP1140273A2 Device for locally delivering a drug in a body cavity
10/10/2001EP1140242A1 Polymer compositions for intraluminal stent
10/10/2001EP1140240A1 Injectable hyaluronic acid derivative with pharmaceuticals/cells
10/10/2001EP1140209A1 Blood pool agents for nuclear magnetic resonance diagnostics
10/10/2001EP1140204A2 Vitronectin receptor antagonist pharmaceuticals
10/10/2001EP1140200A1 Anthraquinone anticancer drugs
10/10/2001EP1140199A1 Hyaluronate lyase used for promoting penetration in topical agents
10/10/2001EP1140198A1 A composition and method for the enhancement of the efficacy of drugs
10/10/2001EP1140197A1 Soluble compositions of toremifene
10/10/2001EP1140196A1 Soluble compositions of triphenylethylene antiestrogens
10/10/2001EP1140195A1 Oil-in-water emulsion exhibiting a protective action against damages to human organs resulting from peroxidation, and the production and use thereof
10/10/2001EP1140194A2 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combined treatment of neoplasia
10/10/2001EP1140193A2 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
10/10/2001EP1140192A2 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia
10/10/2001EP1140191A1 Combinations of ileal bile acid transport inhibitors and nicotinic acid derivatives for cardiovascular indications
10/10/2001EP1140190A1 Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indications
10/10/2001EP1140189A1 Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications
10/10/2001EP1140188A1 Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications
10/10/2001EP1140187A1 Combinations for cardiovascular indications
10/10/2001EP1140186A1 Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
10/10/2001EP1140185A1 Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications
10/10/2001EP1140184A1 Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications
10/10/2001EP1140183A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia
10/10/2001EP1140182A2 Use of a matrix metalloproteinase inhibitor together with an antineoplastic agent, optionally also together with radiation, in the treatment of neoplasia
10/10/2001EP1140181A1 Combination therapy of radiation and a cox-2 inhibitor for the treatment of neoplasia
10/10/2001EP1140179A2 Use of a cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia
10/10/2001EP1140178A2 Use of a matrix metallaproteinase inhibitor and radiation as a combined treatment of neoplasia
10/10/2001EP1140177A2 Use of an integrin antagonist and radiation in the treatment of neoplasia
10/10/2001EP1140176A1 Transcutaneous photodynamic treatment of targeted cells
10/10/2001EP1140163A2 Combination of hepatitis b vaccine with antiviral agents
10/10/2001EP1140154A2 Chorionic gonadotropin dna vaccines and methods
10/10/2001EP1140147A2 hCG THERAPY FOR THE TREATMENT OF BREAST CANCER
10/10/2001EP1140143A2 Ribavirin-pegylated interferon alfa induction hcv combination therapy
10/10/2001EP1140141A2 Methods for treating cancer and for mediating chemotaxis of dendritic cells
10/10/2001EP1140140A2 Composition and method for improving function of embryonic kidney transplants
10/10/2001EP1140136A2 Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
10/10/2001EP1140134A1 Agent for treating visual cell function disorder
10/10/2001EP1140127A1 Antiprotozoal saponins
10/10/2001EP1140126A1 A nascent gold based herbal composition
10/10/2001EP1140120A2 Human brainiac-5
10/10/2001EP1140119A1 Novel therapeutic application of low molecular weight heparin
10/10/2001EP1140118A1 Cyclic adenosine diphosphate ribose analogues for modulating t cell activity
10/10/2001EP1140117A2 Aciclovir compositions containing dimethicone
10/10/2001EP1140116A1 Use of adenosine agonists in cancer therapy
1 ... 5997 5998 5999 6000 6001 6002 6003 6004 6005 6006 6007 6008 6009 6010 6011 6012 6013 6014 6015 6016 6017 ... 7860